Doing cancer trials in India: opportunities and pitfalls

被引：4

作者：

Raina, V ^{[1
]}

机构：

[1] All India Inst Med Sci, Dept Med Oncol, Inst Rotary Canc Hosp, New Delhi, India

来源：

关键词：

D O I：

10.1093/annonc/mdi315

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1567 / 1568

页数：2

共 11 条

[1]

Bagla P, 2001, SCIENCE, V293, P2371

Bagla, P ;

Marshall, E .

Jayaraman, KS .

[4]

Mani LH, 1997, NATL MED J INDIA, V10, P249

[5] Indian doctors defend "unethical" anticancer drug trial [J].

Mudur, G .

BRITISH MEDICAL JOURNAL, 2001, 323 (7308) :299-299

[6]

*NCRP ICMR, 2005, 2 YEAR REP POP BAS C

[7] A new colonialism? Conducting clinical trials in India [J].

Nundy, S ;

Gulhati, CM .

[8] Use of new cancer drugs in India [J].

Pal, SK .

[9] Standard protocol helps improve ALL survival rates in India [J].

Sharma, DC .

[10]

SLEDGE CW, 41 ANN M ASCO 2005, P698